Chris Unwin serves as the Director of Supply Chain & Logistics at Stratpharma AG, where he leverages his extensive international experience to drive operational excellence across the organization. With a robust background in supply chain management and logistics, Chris is responsible for overseeing all facets...
Chris Unwin serves as the Director of Supply Chain & Logistics at Stratpharma AG, where he leverages his extensive international experience to drive operational excellence across the organization. With a robust background in supply chain management and logistics, Chris is responsible for overseeing all facets of the supply chain, including 3rd Party Manufacturing, ensuring that products are delivered efficiently and effectively to meet global market demands. His leadership is characterized by a hands-on approach that inspires and motivates diverse, multilingual teams, fostering a culture of collaboration and innovation.
At Stratpharma AG, Chris has spearheaded key projects that have significantly enhanced the company's operational capabilities. His strategic oversight in project planning and execution has led to the successful implementation of advanced ERP systems, optimizing inventory management and streamlining purchasing processes. By focusing on strategic sourcing and warehousing solutions, he has improved cost efficiencies while maintaining high-quality standards in manufacturing.
Chris's expertise in cross-functional team leadership is evident in his ability to navigate the complexities of global supply chains, particularly during economic fluctuations. His proven track record of managing and inspiring teams through challenging times underscores his commitment to fostering resilience and adaptability within the workforce. As a seasoned executive, Chris continues to drive innovation at Stratpharma AG, positioning the company for sustainable growth in an increasingly competitive landscape. His blend of strategic vision and operational acumen makes him a pivotal figure in the organization’s ongoing success.